Two-Part, Phase Ib/II, Open Label, Single-Arm, Multi-center Study to Evaluate the Safety and Efficacy of Varlitinib in Combination With Weekly Paclitaxel in EGFR/HER2 Co-expressing Advanced or Metastatic Gastric Cancer Patients

NCT05400915 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
27
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Yonsei University